Pisa

• A Study of Disitamab Vedotin Alone and with Pembrolizumab in Urothelial Cancer That Expresses HER2 Not authorised
  2022-500030-28-00 4 Urothelial carcinoma
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Not authorised
  2022-500535-36-00 5 Moderately to severely active ulcerative colitis
• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 5 Moderately to severely active ulcerative colitis
• A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination with Chemotherapy for the First Line Treatment for Pati … Not authorised
  2022-502043-35-00 5 Advanced Biliary Tract Cancers
• A clinical study of people with HIV‐1 who switch their treatment to a combination of doravirine and islatravir​​ Not authorised
  2022-502079-49-00 5 HIV-1 infection
• Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Not authorised
  2023-503634-50-00 5 Anemia in patients with chronic kidney disease on dialysis
• Pressurized intrathoracic aerosol chemotherapy (PITAC) in patients with malignant pleural effusion: a single-center phase II trial. PITAC_ M … Not authorised
  2024-511255-17-00 4 Pleural carcinosis
• MELFLUFEN FOR ELDERLY PATIENTS WITH RELAPSED MYELOMA Not authorised
  2024-514652-33-00 4 Relapsed Multiple Myeloma
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Unknown
  2022-502779-40-99 5 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• A Phase 1/2a Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-DM1 in Subjects With … Pending
  2024-513579-42-00 7 Type 1 Myotonic Dystrophy
• Extension Study of ACT-EARLY Pending
  2024-513676-18-00 5 Transthyretin Amyloidosis
• A 52 week study in which neither Sponsor or participant know the treatment assigned to subjects to compare the experimental drug (CHF 5993) … Pending
  2024-514248-95-00 5 Uncontrolled Asthma
• PIrfenidone to prevent fibrOsis in ARDS. A RaNdomizEd controllEd tRial - PIONEER Pending
  2024-514355-16-01 5 Acute Respiratory Distress Syndrome (ARDS)
• A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinson’s Disease Pending
  2024-515448-22-00 4 Parkinson Disease, Idiopathic
• An open-label extension study evaluating the safety of zagociguat in participants with MELAS who completed TIS6463-203 Pending
  2024-517514-15-00 4 Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like epis
• Use of Sulodexide (VESSEL®) for the prevention of a new episode in elderly patients who have had a first episode of deep vein thrombosis and … Pending
  2024-517796-21-00 5 Prevention of recurrence after a first episode of Venous Thromboemboli
• A multicenter open-label phase II study of Cemiplimab plus chemotherapy, selected on the basis of baseline cytidine deaminase activity, in a … Pending
  2024-517799-40-00 4 Advanced squamous non-small cell lung cancer
• A PROJECT FOR TWO MULTICENTRE, PROSPECTIVE OPEN LABEL RANDOMIZED CLINICAL STUDIES TO EVALUATE THE EFFECT OF TARGETED THERAPY BASED ON KIDNEY … Pending
  2024-517861-18-00 5 Idiopathic IgA nephropathy (IgAN)
• Study of Antibiotic Combinations in Early Breast Cancer Pending
  2024-517993-94-00 4 Breast Cancer
• Atezolizumab, Pertuzumab and Trastuzumab with chemotherapy as neoadjuvant treatment of HER2 positive early high-risk and locally advanced br … Pending
  2024-518026-32-00 5 Invasive Breast Cancer
• Phase II single arm study with CABozantinib in Non-Small Cell Lung Cancer patients with MET deregulation Pending
  2024-518386-95-02 4 Non small-cell lung cancer
• A phase III, randomized, controlled, open label, no profit, single-center intervention study to compare the effect of a conservative (antith … Pending
  2024-518452-23-00 5 Graves' disease and Graves' orbitophaty
• The effect of phoSPHocreatine on mEdical emergency team (met) tREated patients: a randomized clinical trial protocol – SPHERE Pending
  2024-518474-14-00 5 respiratory arrest
• Role in GVHD prophylaxis of Vitamin D in patients undergoing allogeneic transplantation of stem cells. Phase II Pilot Study Pending
  2024-518738-97-00 4 haematologic condition who need staminal cells transplant

Showing 1–24 of 552 trials